FTC secures partial win against AbbVie
RiverNorthPhotography / iStockphoto.com
The Federal Trade Commission (FTC) has found after a public comment period that Abbott Laboratories’ $25 billion acquisition of St. Jude Medical would probably be anti-competitive.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
FTC, Abbott, M&A, anticompetitive, St. Jude Medical, Terumo Corporation